P M Flanagan|A M Flanagan - JoVE Visualize

Showing results (31-40 of 94) with videos related to

Pageof 10

Sort By:

Science (New York, N.Y.)|November 3, 1989

Initiation by yeast RNA polymerase II at the adenoviral major late promoter in vitroN F Lue, P M Flanagan, K Sugimoto, et al.

Skeletal Radiology|September 8, 2004

Chondroid lipoma: correlation of imaging findings and histopathology of an unusual benign lesionR A R Green, S R Cannon, A M Flanagan

International Journal of Experimental Pathology|February 1, 1995

The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitroA M Flanagan, M D Stow, N Kendall, et al.

Biochemical and Biophysical Research Communications|May 31, 1991

Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitroG Hattersley, J Owens, A M Flanagan, et al.

Bone|November 14, 1997

Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissueC K Lea, H Ebrahim, S Tennant, et al.

Skeletal Radiology|October 13, 2005

Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studiesP O'Donnell, T C Diss, J Whelan, et al.

British Journal of Haematology|February 13, 2001

Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expressionC S Lader, J Scopes, M A Horton, et al.

Bone|June 27, 2001

Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironmentH M Massey, J Scopes, M A Horton, et al.

Cell Proliferation|May 3, 2007

Inhibition of gamma-secretases alters both proliferation and differentiation of mesenchymal stem cellsS Vujovic, S R Henderson, A M Flanagan, et al.

The Journal of Endocrinology|March 31, 1998

Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogenC K Lea, V Moxham, M J Reed, et al.

Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:

Pageof 10

Science (New York, N.Y.)|November 3, 1989

Initiation by yeast RNA polymerase II at the adenoviral major late promoter in vitroN F Lue, P M Flanagan, K Sugimoto, et al.

Skeletal Radiology|September 8, 2004

Chondroid lipoma: correlation of imaging findings and histopathology of an unusual benign lesionR A R Green, S R Cannon, A M Flanagan

International Journal of Experimental Pathology|February 1, 1995

The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitroA M Flanagan, M D Stow, N Kendall, et al.

Biochemical and Biophysical Research Communications|May 31, 1991

Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitroG Hattersley, J Owens, A M Flanagan, et al.

Bone|November 14, 1997

Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissueC K Lea, H Ebrahim, S Tennant, et al.

Skeletal Radiology|October 13, 2005

Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studiesP O'Donnell, T C Diss, J Whelan, et al.

British Journal of Haematology|February 13, 2001

Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expressionC S Lader, J Scopes, M A Horton, et al.

Bone|June 27, 2001

Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironmentH M Massey, J Scopes, M A Horton, et al.

Cell Proliferation|May 3, 2007

Inhibition of gamma-secretases alters both proliferation and differentiation of mesenchymal stem cellsS Vujovic, S R Henderson, A M Flanagan, et al.

The Journal of Endocrinology|March 31, 1998

Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogenC K Lea, V Moxham, M J Reed, et al.

Pageof 10